Asymchem Labs A/H Listing Early Look - Fast Growing, Relatively Insulated
Asymchem Laboratories (002821 CH) (AL) aims to raise around US$1-1.5bn in its H-share listing in Hong Kong. The A-shares listed were listed in...
210 Views
Wuxi Biologics Placement - Similar Deal Will Yield Similar Results
Wuxi Biologics Holdings is looking to raise up to US$1.3bn by selling about 1.8% of Wuxi Biologics (2269 HK). This is the company's 15th placement...
352 Views
HCM Secondary Trading: NPMA Approvals Warrant a Pop on Debut
We look updates from HCM since it launched its book building. We note that the recent NMPA approval will result in a share price pop on debut.
194 Views
China Healthcare Weekly (Jun.25)
This article analyzed the results of 5th national volume-based purchase, the new announcement on the centralized procurement of artificial joints,...
218 Views
Pre-IPO Hutchmed China Ltd (13.HK) - The Strength and the Concerns
The article analyzed Hutchmed in terms of its business analysis, financial performance, pipeline, comparison with other biotech companies, and also...
262 Views